SCHEMBL6941814

SCHEMBL6941814

Cc1cc2ccccc2n1CCC(O)CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.46
KDM4E B2RXH2 3/20 0.46
MEN1 O00255 9/20 0.43
KMT2A Q03164 9/20 0.43
HTT P42858 3/20 0.43
TSHR P16473 3/20 0.41
MAPT P10636 7/20 0.40
SMN1; SMN2 Q16637 6/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
CYP2C19 P33261 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CYP2C9 P11712 2/20 0.40
HSP90AA1 P07900 1/20 0.40
PKM P14618 1/20 0.40
POLB P06746 3/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6941805 1.00 TP53 (0.46) TP53KDM4EMEN1KMT2AHTT
SCHEMBL6933502 0.81 CDK4 (0.45) MEN1KMT2AHTTTSHRMAPT
SCHEMBL6933500 0.81 CDK4 (0.45) MEN1KMT2AHTTTSHRMAPT
SCHEMBL7846514 0.77 TP53 (0.41) TP53KDM4EMEN1KMT2AHTT
SCHEMBL6940900 0.76 ADA (0.45) TP53KDM4E
SCHEMBL7846509 0.75 TP53 (0.41) TP53KDM4EMEN1KMT2AHTT
SCHEMBL6938178 0.74 TK1 (0.40) KDM4EMEN1KMT2AHTTMAPT
SCHEMBL6938174 0.74 TK1 (0.40) KDM4EMEN1KMT2AHTTMAPT
SCHEMBL6939242 0.71 BCL2 (0.46) MEN1KMT2ANPC1RAB9A
SCHEMBL6939234 0.71 BCL2 (0.46) MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596738-B1 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 US disclosed